POST Online Media Lite Edition


Fujifilm to buy Biogen Danish subsidiary for $890 million

Staff Writer |
Fujifilm Holdings Corp said it is buying a subsidiary of Biogen for around $890 million to bolster its healthcare business.

Article continues below

It said it expects the acquisition of Biogen Denmark Manufacturing ApS to be completed in August.

The Denmark unit has a facility equipped with six 15,000 liter bioreactors that can manufacture cell culture-derived biologics.

Biogen said it expects the site’s 800 staff to remain employed.

Through the acquisition, Fujifilm aims to achieve its 100 billion yen ($897.91 million) revenue target in its contact development and manufacturing organization (CDMO) business by 2021, two years ahead of its original goal.

What to read next

Fujifilm to acquire Cellular Dynamics International
Biogen announces $5 billion share repurchase
Major Xerox investor sues to block takeover by Fujifilm